DrugClass

Hidradenitis suppurativa: identification, symptoms and management

How to recognise the signs and symptoms of this chronic skin condition, with advice on pharmacological management.…

Kidney stones: symptoms, diagnosis and management

Kidney stones are a source of significant patient morbidity. Pharmacists can have an impact in identifying, triaging and supporting patients with the management of this condition.…

Statin prescribing in England at record high, show NICE data

Figures show that atorvastatin prescribing increased from 4.2 million people in 2022/2023 to 5.0 million people in 2023/2024.…

Medicines regulator receives 46 reports of hospitalisations linked to weight-loss drugs

As of 16 August 2024, the MHRA had received 5,073 reports of common gastrointestinal reactions related to GLP-1 RA use, of which 46 reported hospitalisation of the individual.…

Test your knowledge of cardiovascular disease

This CPD and learning quiz can help you assess your knowledge of cardiovascular disease and related health issues.…

Government-funded trial will test psilocybin as treatment for opioid use disorder

The project is one of four funded by the National Institute for Health and Care Research aimed at cutting harm from illegal drugs.…

Pharmacist-led cardiovascular disease interventions provide highest return on investment, says NHS report

The report measured return on investment over five years of a range of interventions, including smoking cessation, cardiovascular disease and substance abuse.…

Nitazenes linked to 179 deaths in 12 months, government data show

According to data analysis by the Office for Health Improvement and Disparities, protonitazene was linked to the most reported deaths — 73 out of 179.…

Cardiac chest pain: identification, referral and management in primary care

Chest discomfort is a common symptom with several possible causes. This article outlines how pharmacists can differentiate symptoms and identify when patients are likely to be experiencing myocardial ischaemia.…

Manufacturer withdraws treatment for sickle cell disease following concern over deaths

Pfizer's withdrawal is based on data that suggest “an imbalance in vast-occlusive crises and fatal events which require further assessment”.…